CEimpact Podcast

The Drug Supply Chain Security Act (DSCSA) is intended to identify counterfeit drugs and keep patients safe. Many believe it is the wholesaler's responsibility. But the success of DSCSA ultimately depends on the frontline pharmacist.In November 2023, pharmacists will have operational responsibility to ensure DSCSA is being followed.

Learn more by listening to this podcast that features:
Jake Galdo, CEimpact Podcast Host
Mark Tate, President, InfiniTrak
Sam Pizzo, Senior Vice President, Strategic Alliances, InfiniTrak

InfiniTrak is a dispenser-friendly tool to ensure compliance for DSCSA. 

To learn more about CEimpact and our memberships, visit http://ceimpact.com today. 

Follow CEimpact on Social Media:
LinkedIn
Instagram

Long COVID, or PostAcute Sequelae of SARS-CoV-2 Infection (PASC), was identified early in the pandemic. With over 200 symptoms attributed to PASC, join host, Geoff Wall, as he evaluates a seminal paper describing the diagnostic criteria, symptoms, and incidence of Long COVID.
 
The GameChanger
The PASC score can be used to detect Long COVID and help establish patients into care.
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Reference
Thaweethai T, Jolley SE, Karlson EW, et al. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. Published online May 25, 2023. doi:10.1001/jama.2023.8823

https://recovercovid.org/

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Apply the PASC score to a patient with Long COVID.
2. Describe the limitations of the RECOVER study. 

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-236-H01-P
Initial release date: 7/3/2023
Expiration date: 7/3/2024
Additional CPE details can be found here.

This podcast episode was financially supported through grant funding from Ananda Professional. 

Want to learn more about CBD as an expanded pharmacy service? Join the CBD Academy in the CEimpact App by CLICKING HERE.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Visit http://ceimpact.com to learn more about what we do. 

Follow CEimpact on Social Media:
LinkedIn
Instagram

Non-alcoholic fatty liver disease (NAFLD) is a primary cause of chronic liver disease and cirrhosis. Join host, Geoff Wall, as he evaluates new data on the diagnosis and treatment of NAFLD.
 
The GameChanger
Historical treatment of NAFLD includes beta-blockers, diuretics, and lactulose for hepatic encephalopathy. Newer agents include statins, pioglitazone, and even vitamin E.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
Tapper EB, Parikh ND. Diagnosis and Management of Cirrhosis and Its Complications: A Review. JAMA. 2023 May 9;329(18):1589-1602. doi: 10.1001/jama.2023.5997. PMID: 37159031.

Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
 
CE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the treatment of cirrhosis and subsequent complications
2. Develop treatment recommendations for persons with NAFLD

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-235-H01-P
Initial release date: 6/26/2023
Expiration date: 6/26/2024
Additional CPE details can be found here.

This podcast episode was financially supported through grant funding from Ananda Professional. 

Want to learn more about CBD as an expanded pharmacy service? Join the CBD Academy in the CEimpact App by CLICKING HERE.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Visit http://ceimpact.com to learn more about what we do. 

Follow CEimpact on Social Media:
LinkedIn
Instagram

Many of us avoid giving feedback because it can feel negative and uncomfortable. We’re afraid of a poor reaction from the student and we really don’t want to hurt their feelings – after all – they already have so much pressure on them. And let’s be honest - sometimes, we just want to be liked.

And yet as preceptors, giving good feedback is probably one of the most important jobs we have. If our learners – whether students or residents - are going to be successful, deliver excellent patient care, and even keep patients safe, they’ve got to hear some tough feedback every now and again. If we’re being truthful – so do we.

Dr. Shannon James from Husson University joined me for a discussion about giving good feedback to learners. Her thoughtful and fearless approach to this really resonated with me and I hope it does for you, too.

Host
Kathy Schott, PhD
CEimpact
 
Guest
Shannon James, PharmD, BCPP
Assistant Professor of Pharmacy Practice
Husson University School of Pharmacy

About Dr. James:
Dr. Shannon James is a Board Certified Psychiatric Pharmacist and an Assistant Professor of Pharmacy Practice at the Husson University School of Pharmacy. Shannon earned B.S. Pharmaceutical Studies and Doctor of Pharmacy degrees at the University of Kansas. After graduation, she completed a PGY1 Pharmacy Practice residency at the New Mexico VA Health Care System in Albuquerque, NM followed by a PGY2 Psychiatric Pharmacy residency at Community Health Network and Butler University in Indianapolis, IN. She is a certified Mental Health First Aid instructor and is involved in grant-funded efforts to improve access to harm reduction resources for opioid use disorder in Maine. Her clinical interests include severe mental illness, substance use disorders, and patient advocacy.

CE Information
At the end of this course, preceptors will be able to:
1. Describe strategies for effective feedback.
2. Discuss how establishing a set of core assumptions about learners can assist in delivering effective feedback.

UAN: 0107-0000-26-257-H99-P
Release Date: June 21, 2026
Planned Expiration Date: June 21, 2029

The speakers have no relevant financial relationships with ineligible companies to disclose.

This program has been:
Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Half of patients with heart failure have Heart Failure with Preserved Ejection Fraction (HFpEF).  Join host, Geoff Wall, as he talks about the new guidelines from the American College of Cardiology for diagnosis, treatment, and challenges in therapy for persons with HFpEF.

The GameChanger
HFpEF is the fastest growing cause of heart failure and is often difficult to diagnose. New therapies are shown to improve symptoms and decrease hospitalizations. Management of comorbid conditions, like obesity and diabetes, is critical to optimizing care.
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Reference
Kittleson MM, Panjrath GS, Amancherla K, et al. 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection Fraction: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023 May 9;81(18):1835-1878. doi: 10.1016/j.jacc.2023.03.393. Epub 2023 Apr 19. PMID: 37137593.
 
Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the H2FPEF scoring system for HFpEF diagnosis
2. Apply the new practice guidelines to HFpEF patient pharmacotherapy
 
0.05 CEU/0.5 Hr
UAN: 0107-0000-23-228-H01-P
Initial release date: 6/19/2023
Expiration date: 6/19/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Adulteration of medications of abuse is a rampant issue in the US. Most attention is on opioids; however, benzodiazepine adulteration is occurring – with sulfonylureas. Join host, Geoff Wall, as he talks about managing emergent hypoglycemia episodes.
 
The GameChanger
Several case reports have detailed patients unresponsive due to severe hypoglycemia caused by mistaken sulfonylurea ingestion. Treatment of acute sulfonylurea overdose includes dextrose and octreotide.

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources
 Tucker, M. Sulfonylureas as Street Drugs: Hidden Hypoglycemia Cause. Medscape.
May 2023. https://www.medscape.com/viewarticle/991680
 
Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
 
CE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the phenomenon of ‘street valium’ overdoses
2. Discuss the treatment of severe sulfonylurea overdose

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-227-H01-P
Initial release date: 6/12/2023
Expiration date: 6/12/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Septic shock has a 40% mortality rate in many patients. Methylene blue has been shown in small non-controlled case series to have a benefit. Join host, Geoff Wall, as he reviews a randomized controlled study from Mexico on this novel strategy.
 
The GameChanger
Methylene blue is a specific inhibitor of the inducible nitric oxide synthase for indirect pressor effects. Despite confounders, this small study may be a good start for a larger randomized controlled study for methylene blue as early adjunct care in patients with septic shock.
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
 
Reference
Ibarra-Estrada M, Kattan E, Aguilera-González P, et al. Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial. Crit Care. 2023 Mar 13;27(1):110. doi: 10.1186/s13054-023-04397-7. PMID: 36915146; PMCID: PMC10010212.
 
Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

 

CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the potential physiologic mechanism of benefit for methylene blue in septic shock
2. Discuss the Ibarra-Estrada et al study limitations

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-212-H01-P
Initial release date: 6/5/2023
Expiration date: 6/5/2024
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

The proverbial ‘pill’ or hormonal contraception may be available over-the-counter (or at least a progestin-only version) by year’s end. Join guest host, Jake Galdo, as he discusses improved access to care with Erin Raney as the FDA debates over-the-counter status for hormonal contraceptives.

The GameChanger
Women’s health is a priority area from a public health perspective – the US has lots of room for improvement. One initiative is to allow a progestin-only hormonal contraceptive have over-the-counter status; in other words, be available without a prescription. Progestin-only therapy has unique counseling considerations, so pharmacy intervention can help to optimize care. 

Host
Jake Galdo, PharmD, MBA, BCPS, BCGP
Course Content and Developer, CEimpact
Managing Network Facilitator, CPESN Health Equity
CEO, Seguridad

Guest
Erin C. Raney, Pharm.D., BCPS, BC-ADM
Professor of Pharmacy Practice
Midwestern University College of Pharmacy-Glendale

References and Resources
Opill Rx-to-OTC Switch Program. www.fda.gov/media/167893/download

Pharmacist Members, REDEEM YOUR CPE HERE!

Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the efficacy of OTC hormonal contraceptive
2. Identify contraindications for OTC hormonal contraceptives

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-211-H01-P
Initial release date: 5/29/2023
Expiration date: 5/29/2024

Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram